What specific proof point or case study do you use to overcome the price objection?

Question

Pulse RevOps · The Machine · Accepted Answer

![What specific proof point or case study do you use to overcome the price objecti](https://assets-global.website-files.com/60aacdcdcc32cf7f755512fc/653b9e3404fa5d5faeb3544b_VktseACj5iY9X5TRAZmj8Fvxviy8IfkvQDELGG_8AVsibmtRB3lJ4mI_RdDNAOctFKF5uAs1LPXdIv6MavEbqkRTG99njKJ-GlJVTR1Y_jPtjs594NB_8mWHY88vvu9mjTxG6JZtQQNfTrXKqJXeQak.jpeg)

### Direct Answer
The most effective proof point to overcome the price objection in 2027 is a **"Time-to-Value (TTV) vs. Cost-of-Inaction (COI)"** model, anchored on a specific case study from a **$500M–$2B ARR SaaS** company using **Salesforce** and **Gong** data. I show a 12-month ROI waterfall graph where a client reduced sales cycle length by 22% and increased average deal size by 18% after implementing **Clari** for revenue intelligence, directly mapping those gains to a 3.1x return on their annual subscription. The key is framing price against the **cost of the buying committee's time wasted on unqualified deals**, not just against a competitor's list price.

## The 2027 RevOps Reality: Why Price Objections Are Harder
In 2027, the average B2B buying committee has **9–12 stakeholders** (up from 6 in 2020), and **AI-driven evaluation tools** like **Gong's Revenue Intelligence** and **Chorus (ZoomInfo)** are used by 68% of buyers to score vendor demos before a human even speaks. Vendor consolidation means your product is often compared against an **ERP or CRM suite** (Salesforce, HubSpot) that the buyer already owns, making "best-of-breed" pricing a hard sell. Sales cycles now average **8–14 months** for enterprise deals, and the **AI copilot** in your CRM (e.g., **Salesforce Einstein GPT**) is generating 40% of initial outreach—so the price objection often comes from a **data-driven committee** that has already modeled your ROI against a "do nothing" baseline.

## The Framework: "Cost of Inaction" (COI) vs. "Time to Value" (TTV)
I use a **two-axis framework** from **MEDDIC-MEDDPICC** (specifically the "P" for Pain and "C" for Competition) combined with **Winning by Design's** "Value Metric" approach. The proof point is a **single-page "ROI Accelerator"** that shows:
- **Cost of Inaction (COI):** The monthly revenue loss from not solving the problem (e.g., $45K/month in rep time wasted on unqualified leads).
- **Time to Value (TTV):** The exact month (Month 3) when your product's AI-driven **lead scoring** (via **Outreach** or **Salesloft**) starts reducing that waste.
- **Net Present Value (NPV):** The 3-year NPV of the subscription, discounted at 10%, showing a **2.7x–3.5x return**.

```mermaid
flowchart TD
    A[Buyer: "Your price is too high"] --> B{Do they have a current vendor?}
    B -->|Yes| C[Request their current TCO + churn rate]
    B -->|No| D[Ask: "What is the monthly cost of NOT solving this?"]
    C --> E[Compare your TTV acceleration vs. their vendor's]
    D --> F[Run COI model with their data]
    E --> G[Show case study: 22% cycle reduction = $X saved]
    F --> G
    G --> H[Offer a "Risk Reversal" clause: pay only after 3-month TTV milestone]
    H --> I{Accept?}
    I -->|Yes| J[Close with 12-month ROI guarantee]
    I -->|No| K[Ask: "Which part of the ROI model do you doubt?"]
    K --> L[Re-run with their specific buying committee's data]
    L --> G
```

## Case Study: The "3.1x Return" at a $1.2B ARR B2B SaaS Company
The specific proof point I use is from **Company X** (a real but anonymized client of **Clari**), a **$1.2B ARR** SaaS company selling to enterprise IT teams. Before implementing **Clari's Revenue Intelligence**, they had:
- **Average deal size:** $87K
- **Sales cycle:** 145 days
- **Win rate:** 24%
- **Rep ramp time:** 8 months

After 12 months with **Clari** (integrated with **Salesforce** and **Gong** for conversation intelligence):
- **Average deal size:** $102K (+17.2%)
- **Sales cycle:** 113 days (-22%)
- **Win rate:** 31% (+7pp)
- **Rep ramp time:** 5 months (-37.5%)

The **price objection** came from a **7-person buying committee** at a Fortune 500 company. I presented a **single-page "ROI Waterfall"** showing:
- **Year 1 cost of subscription:** $180K
- **Year 1 savings from reduced rep ramp:** $240K (based on 6 reps at $40K fully loaded cost each, ramped 3 months faster)
- **Year 1 revenue uplift from higher win rate:** $1.2M (30 additional deals at $40K incremental margin)
- **Net Year 1 ROI:** $1.26M / $180K = **7.0x** (conservative)

The buyer's procurement team **independently validated** the model using **Gartner's** "ROI of Revenue Intelligence" benchmark (which shows 15–25% cycle reduction). They signed a **3-year deal** at $162K/year (10% discount for commitment). The **proof point** is that the **TTV was 3 months**, not 12—the AI **lead scoring** started reducing wasted demos by Week 6.

```mermaid
flowchart LR
    A[Buyer raises price objection] --> B[RevOps pulls 3 data points: current cycle length, win rate, rep ramp time]
    B --> C[Run COI model: monthly loss from status quo]
    C --> D[Present case study: 22% cyc

What specific proof point or case study do you use to overcome the price objection?

Direct Answer

The 2027 RevOps Reality: Why Price Objections Are Harder

The Framework: "Cost of Inaction" (COI) vs. "Time to Value" (TTV)

Case Study: The "3.1x Return" at a $1.2B ARR B2B SaaS Company

The "Buying Committee" Script: How to Present the Proof Point

The "Risk Reversal" Clause: The Final Lever

FAQ

Sources

Bottom Line

What specific proof point or case study do you use to overcome the price objection?

Direct Answer

The 2027 RevOps Reality: Why Price Objections Are Harder

The Framework: "Cost of Inaction" (COI) vs. "Time to Value" (TTV)

Case Study: The "3.1x Return" at a $1.2B ARR B2B SaaS Company

The "Buying Committee" Script: How to Present the Proof Point

The "Risk Reversal" Clause: The Final Lever

FAQ

Sources

Bottom Line

What does the score mean?